ACAD logo

ACADIA Pharmaceuticals Inc. (ACAD) Total expenses

Annual total expenses:

$873.52M+$73.70M(+9.21%)
December 31, 2024

Summary

  • As of today (August 31, 2025), ACAD annual total expenses is $873.52 million, with the most recent change of +$73.70 million (+9.21%) on December 31, 2024.
  • During the last 3 years, ACAD annual total expenses has risen by +$218.93 million (+33.45%).
  • ACAD annual total expenses is now at all-time high.

Performance

ACAD Total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherACADincome statement metrics

Quarterly total expenses:

$237.90M+$12.57M(+5.58%)
June 30, 2025

Summary

  • As of today (August 31, 2025), ACAD quarterly total expenses is $237.90 million, with the most recent change of +$12.57 million (+5.58%) on June 30, 2025.
  • Over the past year, ACAD quarterly total expenses has increased by +$29.33 million (+14.06%).
  • ACAD quarterly total expenses is now -14.08% below its all-time high of $276.88 million, reached on September 30, 2023.

Performance

ACAD Quarterly total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherACADincome statement metrics

Total expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

ACAD Total expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+9.2%+14.1%
3 y3 years+33.5%+41.1%
5 y5 years+49.2%+56.3%

ACAD Total expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+33.5%-14.1%+105.3%
5 y5-yearat high+49.2%-14.1%+105.3%
alltimeall timeat high+5506.3%-14.1%>+9999.0%

ACAD Total expenses History

DateAnnualQuarterly
Jun 2025
-
$237.90M(+5.6%)
Mar 2025
-
$225.33M(+94.5%)
Dec 2024
$873.52M(+9.2%)
$115.86M(-46.8%)
Sep 2024
-
$217.64M(+4.3%)
Jun 2024
-
$208.57M(+10.2%)
Mar 2024
-
$189.28M(+2.2%)
Dec 2023
$799.82M(+8.0%)
$185.24M(-33.1%)
Sep 2023
-
$276.88M(+68.7%)
Jun 2023
-
$164.12M(+1.6%)
Mar 2023
-
$161.48M(-9.4%)
Dec 2022
$740.83M(+13.2%)
$178.22M(+12.9%)
Sep 2022
-
$157.90M(-6.3%)
Jun 2022
-
$168.57M(-26.2%)
Mar 2022
-
$228.52M(+31.4%)
Dec 2021
$654.58M(-10.1%)
$173.85M(+19.0%)
Sep 2021
-
$146.07M(-8.2%)
Jun 2021
-
$159.09M(-8.0%)
Mar 2021
-
$173.00M(-7.9%)
Dec 2020
$728.34M(+24.4%)
$187.77M(-8.5%)
Sep 2020
-
$205.24M(+34.8%)
Jun 2020
-
$152.24M(-14.5%)
Mar 2020
-
$178.09M(+17.7%)
Dec 2019
$585.62M(+24.3%)
$151.36M(+10.8%)
Sep 2019
-
$136.56M(-1.1%)
Jun 2019
-
$138.15M(-6.8%)
Mar 2019
-
$148.26M(+18.6%)
Dec 2018
$471.25M(+12.9%)
$125.06M(+3.8%)
Sep 2018
-
$120.44M(+0.1%)
Jun 2018
-
$120.33M(+16.6%)
Mar 2018
-
$103.16M(-8.2%)
Dec 2017
$417.31M(+43.8%)
$112.43M(+11.5%)
Sep 2017
-
$100.83M(+3.0%)
Jun 2017
-
$97.92M(-5.1%)
Mar 2017
-
$103.13M(+13.8%)
Dec 2016
$290.15M(+76.2%)
$90.66M(+17.9%)
Sep 2016
-
$76.88M(+7.6%)
Jun 2016
-
$71.42M(+43.5%)
Mar 2016
-
$49.77M(+8.7%)
Dec 2015
$164.67M(+76.4%)
$45.80M(+17.6%)
Sep 2015
-
$38.95M(-1.1%)
Jun 2015
-
$39.38M(-2.5%)
Mar 2015
-
$40.38M(+42.1%)
Dec 2014
$93.35M(+136.7%)
$28.41M(+14.6%)
Sep 2014
-
$24.80M(+15.2%)
Jun 2014
-
$21.52M(+20.5%)
Mar 2014
-
$17.86M(+47.8%)
DateAnnualQuarterly
Dec 2013
$39.44M(+52.9%)
$12.09M(+10.5%)
Sep 2013
-
$10.94M(+14.7%)
Jun 2013
-
$9.53M(+45.7%)
Mar 2013
-
$6.54M(-9.0%)
Dec 2012
$25.79M(+3.5%)
$7.19M(+22.3%)
Sep 2012
-
$5.88M(-2.3%)
Jun 2012
-
$6.02M(-9.7%)
Mar 2012
-
$6.67M(+13.2%)
Dec 2011
$24.92M(-7.8%)
$5.89M(+4.0%)
Sep 2011
-
$5.66M(-19.3%)
Jun 2011
-
$7.02M(+11.9%)
Mar 2011
-
$6.27M(+0.1%)
Dec 2010
$27.04M(-47.9%)
$6.26M(-4.1%)
Sep 2010
-
$6.53M(-0.9%)
Jun 2010
-
$6.58M(-13.6%)
Mar 2010
-
$7.62M(-27.1%)
Dec 2009
$51.87M(-24.4%)
$10.46M(-6.3%)
Sep 2009
-
$11.16M(-23.3%)
Jun 2009
-
$14.55M(-5.4%)
Mar 2009
-
$15.38M(+7.6%)
Dec 2008
$68.57M(-2.3%)
$14.29M(-10.1%)
Sep 2008
-
$15.90M(-13.9%)
Jun 2008
-
$18.46M(+7.4%)
Mar 2008
-
$17.19M(-7.7%)
Dec 2007
$70.21M(+22.8%)
$18.62M(+3.4%)
Sep 2007
-
$18.00M(+40.6%)
Jun 2007
-
$12.81M(-11.8%)
Mar 2007
-
$14.51M(+2.0%)
Dec 2006
$57.19M(+22.3%)
$14.22M(+7.7%)
Sep 2006
-
$13.21M(-3.9%)
Jun 2006
-
$13.75M(+14.0%)
Mar 2006
-
$12.05M(-4.7%)
Dec 2005
$46.76M(+52.3%)
$12.65M(-20.9%)
Sep 2005
-
$15.98M(+86.9%)
Jun 2005
-
$8.55M(+8.0%)
Mar 2005
-
$7.91M(-6.0%)
Dec 2004
$30.70M(+45.4%)
$8.42M(+8.0%)
Sep 2004
-
$7.80M(+105.6%)
Jun 2004
-
$3.79M(+112.0%)
Mar 2004
-
$1.79M(-15.1%)
Dec 2003
$21.12M(+11.7%)
-
Sep 2003
-
$2.11M(-20.8%)
Jun 2003
-
$2.66M(+15.3%)
Mar 2003
-
$2.31M
Dec 2002
$18.90M(-0.5%)
-
Dec 2001
$18.99M(+21.9%)
-
Dec 2000
$15.58M
-

FAQ

  • What is ACADIA Pharmaceuticals Inc. annual total expenses?
  • What is the all time high annual total expenses for ACADIA Pharmaceuticals Inc.?
  • What is ACADIA Pharmaceuticals Inc. annual total expenses year-on-year change?
  • What is ACADIA Pharmaceuticals Inc. quarterly total expenses?
  • What is the all time high quarterly total expenses for ACADIA Pharmaceuticals Inc.?
  • What is ACADIA Pharmaceuticals Inc. quarterly total expenses year-on-year change?

What is ACADIA Pharmaceuticals Inc. annual total expenses?

The current annual total expenses of ACAD is $873.52M

What is the all time high annual total expenses for ACADIA Pharmaceuticals Inc.?

ACADIA Pharmaceuticals Inc. all-time high annual total expenses is $873.52M

What is ACADIA Pharmaceuticals Inc. annual total expenses year-on-year change?

Over the past year, ACAD annual total expenses has changed by +$73.70M (+9.21%)

What is ACADIA Pharmaceuticals Inc. quarterly total expenses?

The current quarterly total expenses of ACAD is $237.90M

What is the all time high quarterly total expenses for ACADIA Pharmaceuticals Inc.?

ACADIA Pharmaceuticals Inc. all-time high quarterly total expenses is $276.88M

What is ACADIA Pharmaceuticals Inc. quarterly total expenses year-on-year change?

Over the past year, ACAD quarterly total expenses has changed by +$29.33M (+14.06%)
On this page